IDiyas

For the Inventor, By the Inventor

West New York, NJ, United States of America

Alexandre Cote

USPTO Granted Patents = 8 

Average Co-Inventor Count = 9.8

ph-index = 4

Forward Citations = 27(Granted Patents)


Company Filing History:

goldMedal8 out of 10 
 
Nimbus Saturn, Inc.
 patents

Years Active: 2021-2025

Loading Chart...
8 patents (USPTO):
1. 12466841 - Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists (2025-11-11),
2. 12215105 - HPK1 antagonists and uses thereof (2025-02-04),
3. 12071442 - Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists (2024-08-27),
4. 11548890 - HPK1 antagonists and uses thereof (2023-01-10),
5. 11078201 - Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists (2021-08-03),
6. 11034694 - Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists (2021-06-15),
7. 11028085 - Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists (2021-06-08),
8. 11021481 - Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists (2021-06-01),

Title: Innovations by Inventor Alexandre Cote

Introduction

Alexandre Cote is a notable inventor based in West New York, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target HPK1-mediated disorders. With a total of 8 patents to his name, Cote's work is paving the way for new therapeutic options.

Latest Patents

Cote's latest patents include "Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists" and "HPK1 antagonists and uses thereof." These inventions provide compounds, compositions, and methods for inhibiting HPK1, which is crucial for treating various HPK1-mediated disorders. His innovative approach is expected to have a significant impact on the treatment landscape.

Career Highlights

Throughout his career, Alexandre Cote has demonstrated a strong commitment to advancing medical science. His work at Nimbus Saturn, Inc. has allowed him to collaborate with other talented professionals in the field. His dedication to research and development has resulted in multiple patents that contribute to the understanding and treatment of complex medical conditions.

Collaborations

Cote has worked alongside notable colleagues such as Neelu Kaila and Ian Linney. Their combined expertise fosters a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

In summary, Alexandre Cote is a distinguished inventor whose work in the pharmaceutical industry is making strides in the treatment of HPK1-mediated disorders. His innovative patents and collaborations reflect his commitment to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…